Jennifer K. Simpson

Insider Reports History

Location
New York, NY
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jennifer K. Simpson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Panbela Therapeutics, Inc. President and CEO, Director Stock Option (right to buy) 72,800 01 Oct 2024 Direct
EAGLE PHARMACEUTICALS, INC. Director Stock Option (right to buy) 16,253 07 Mar 2023 Direct
LadRx Corp Director Stock Option (Right to Buy) 5,000 15 Jan 2024 Direct

Insider Reports Filed by Jennifer K. Simpson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PBLA Panbela Therapeutics, Inc. 01 Oct 2024 1 $0 4 President and CEO, Director 03 Oct 2024, 16:25
LADX LadRx Corp 15 Jan 2024 1 $0 4 Director 29 Jan 2024, 16:05
PBLA Panbela Therapeutics, Inc. 27 Mar 2023 1 $0 4 President and CEO, Director 29 Mar 2023, 16:26
EGRX EAGLE PHARMACEUTICALS, INC. 07 Mar 2023 1 $0 4 Director 09 Mar 2023, 20:02
PBLA Panbela Therapeutics, Inc. 30 Jan 2023 2 $0 4 President and CEO, Director 01 Feb 2023, 15:37
EGRX EAGLE PHARMACEUTICALS, INC. 28 Feb 2022 1 $0 4 Director 02 Mar 2022, 17:05
LADX CYTRX CORP 15 Dec 2021 1 $0 4/A Director 11 Jan 2022, 20:35
LADX CYTRX CORP 15 Dec 2021 1 $0 4 Director 17 Dec 2021, 09:08
PBLA Panbela Therapeutics, Inc. 13 Sep 2021 1 $0 4 President and CEO, Director 15 Sep 2021, 18:00
LADX CYTRX CORP 29 Jul 2021 0 $0 3 Director 11 Aug 2021, 19:24